FEATURED ARTICLES

• North Carolina Booked Nearly $4 Billion In Investments In 2025

  North Carolina’s life sciences sector saw nearly $3.8 billion in 2025 investments, expanded manufacturing capacity, and major workforce initiatives, reinforcing the state’s position as a national leader.

• Legacy Feeds NC's Resilient Life Sciences Supply Chain Growth

  North Carolina’s expanding life sciences infrastructure is creating one of the world’s most integrated supply‑chain hubs and driving major investment across biopharma, agtech, and regulated research.

• A Year Of Momentum And A Future Full Of Promise

  Charlotte’s life sciences ecosystem accelerated in 2025, anchored by expanding research capabilities. With deeper collaboration on the horizon, the region enters 2026 positioned for even greater momentum.

• Genentech More Than Doubles Initial Holly Springs Investment To $2B

  An expansion in Holly Springs highlights rising momentum, with increased investment, higher production capacity, and hundreds of new jobs. See how this project strengthens regional talent pipelines.

• Eastern NC Biomanufacturing Region Reports Strong Growth

  Eastern North Carolina is rapidly becoming a biomanufacturing powerhouse, capturing most of the state’s recent life sciences investment and job growth while expanding training programs.

• ARPA-H Funds WFIRM-Led Program For On-Demand Bioprinted Kidneys

  A new federal initiative is advancing bioprinted kidney tissue engineered from a patient’s own cells, combining cutting‑edge bioprinting, bioinks, and bioreactors to address the growing donor shortage.

• J&J To Add Another New Drug-Making Facility In Wilson

  Learn more about a major life sciences investment that is bringing 500 new jobs to North Carolina, strengthening U.S. drug manufacturing, and advancing treatments for oncology and neurological diseases.

• Made In NC, Novo Nordisk's Wegovy Pill Is Available Now

  The first oral GLP-1 treatment for obesity is here, delivering significant weight loss and cardiovascular benefits.

• CRO Summit Tackles Cost, Complexity & Collaboration In Trials

  Clinical trials are facing rising costs and complexity. Collaboration, data-driven strategies, and patient-centric models are reshaping research — uncover how leaders drive efficiency and innovation.

• Raleigh-Durham's Life Sciences Cluster Sees Rapid Expansion

  Raleigh-Durham’s life sciences boom in 2025 brings billions in biomanufacturing — and challenges in talent and infrastructure. Explore what’s fueling growth and shaping this U.S. innovation hub.

• Charlotte: A Global Hub For Health Care Innovation And MedTech

  Charlotte’s Pearl is a vibrant hub driving health care innovation — advancing surgery, diagnostics, and digital health through research, education, and medtech collaboration for global impact.

• New Legislation Seeks To Strengthen U.S. Biomanufacturing Sector

  A bipartisan bill aims to create a national center for biopharma manufacturing — boosting U.S. supply chains, workforce training, and global competitiveness in life-saving innovation.

• Novartis To Invest $771M In RTP, Creating Up To 700 Biologics Jobs

  A $771 million expansion will bring new biologics and small molecule manufacturing capabilities and create hundreds of jobs. Learn how this investment positions the Research Triangle for future growth.

• AI Bringing Both Opportunity And Risk In Drug Development

  AI is transforming drug discovery and clinical trials, but success depends on balancing technology with human expertise and ethics. Learn how industry leaders are navigating this shift to accelerate innovation.

• CRO Crown Bioscience Adds Kannapolis Site

  A new Kannapolis site boosts Crown Bioscience’s preclinical oncology services, expanding its U.S. presence. Learn how this move supports innovation in cancer drug development.

• FUJIFILM Biotechnologies Cuts The Ribbon On New Holly Springs Facility

  A new Holly Springs facility boosts U.S. biologics manufacturing with end-to-end capabilities and supply chain resilience—marking a major investment in North Carolina’s life sciences infrastructure.

• Biogen Celebrates 30 Years In RTP And Donates $250,000 To New Lab

  A new biotech lab at Durham Tech, funded by Biogen’s $250K donation, will expand hands-on training and strengthen workforce development in North Carolina’s growing life sciences sector.

• Ypsomed To Invest $249M, Create 62 New Jobs In Holly Springs

  A $249M investment by Ypsomed will bring 62 new jobs and a cutting-edge auto-injector facility to Holly Springs, reinforcing the region’s role in biomanufacturing and drug delivery innovation.

• Genentech Breaks Ground On $700M Facility In Holly Springs

  A major biotech expansion in North Carolina will focus on next-gen obesity treatments, signaling rising demand and shifting manufacturing priorities. Learn what this means for the future.

• Test Bed In Winston-Salem Boosts Emerging Field Of Regenerative Medicine

  Discover a quiet lab in downtown Winston-Salem that is quietly fueling biotech innovation while offering startups free access to cutting-edge equipment and support.